Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Copper(Ii/I) Complexes of 5-Pyridin-2-yl-[1,3]dioxolo[4,5-g] Isoquinoline: Synthesis, Crystal Structure, Antitumor Activity and Dna Interaction

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.

Synthesis, Characterization, and Biological Activities of Two Cu(II) and Zn(II) Complexes with One Polyquinoline Ligand.

Synthesis, Crystal Structure and Photophysical Properties of Cu(I) Complexes Containing 2,5-Bis(pyridyl)-1,3,4-oxadiazole

Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Synthesis, Crystal Structure, DNA-binding Properties, Cytotoxic and Antioxidation Activities of Several Ternary Copper(ii) Complexes with a New Reduced Schiff Base Ligand

Synthesis, DNA binding, photo-induced DNA cleavage, cytotoxicity and apoptosis studies of copper(II) complexes.

Three Structurally Related Copper Complexes with Two Isomers: DNA/BSA Binding Ability, DNA Cleavage Activity and Excellent Cytotoxicity

Synthesis and Structure of Dicopper(Ii) Complexes Bridged by N-(5-Chloro-2-Hydroxyphenyl)-N '[3-(Methy Lamino)Propyl]Oxamide: Evaluation of Dna/Protein Binding, Dna Cleavage, and in Vitro Anticancer Activity

Copper complexes with quinoline-thiosemicarbazone hybrid ligand promoting apoptosis by causing DNA and mitochondria dual lesions

Synthesis and Structures of Binuclear Copper(ii) Complexes Bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxalamide Ligand: DNA-binding Properties and Cytotoxic Activities

Synthesis, Crystal Structure, DNA Interaction and Anticancer Activity of Tridentate Copper(ii) Complexes.

Antitumor copper(II) complexes with hydroxyanthraquinones and N,N-heterocyclic ligands

Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Synthesis, Crystal Structure, Dna Binding, And Oxidative Cleavage Activity Of Copper(Ii)-Bipyridyl Complexes Containing Tetraalkylammonium Groups

Synthesis, cytotoxicity and DNA binding of novel Ni(II), Co(II) and Zn(II) complexes bearing pyrimidinyl hydrazone ligand

Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity

DNA-Binding and Cytotoxicity of Copper(I) Complexes Containing Functionalized Dipyridylphenazine Ligands